Search Results Search Sort by RelevanceMost Recent Medicine and Society Jul 2019 Who Are “Unrepresented” Patients and What Count as “Important” Medical Decisions for Them? David Ozar, PhD A look at current literature and work by a statewide initiative can motivate development of policies that help respond to unrepresented patients’ needs. AMA J Ethics. 2019;21(7):E611-616. doi: 10.1001/amajethics.2019.611. Medicine and Society Feb 2021 Should Clinical Guidelines Incorporate Cost Pathways for Persons With Financial Hardship? David Goldberg, MD Standard treatment of hyperglycemia in type 2 diabetes includes a pathway when “cost is a major issue.” Whether it’s just to do so remains unclear. AMA J Ethics. 2021;23(2):E175-182. doi: 10.1001/amajethics.2021.175. Medicine and Society Jul 2017 Transcending the Tragedy Discourse of Dementia: An Ethical Imperative for Promoting Selfhood, Meaningful Relationships, and Well-Being Peter Reed, PhD, MPH, Jennifer Carson, PhD, and Zebbedia Gibb, PhD Authentic partnerships with people with dementia motivate full social participation and resist fatalism around experiences of illness. AMA J Ethics. 2017;19(7):693-703. doi: 10.1001/journalofethics.2017.19.7.msoc1-1707. Medicine and Society Jul 2017 Arts Participation: Counterbalancing Forces to the Social Stigma of a Dementia Diagnosis Beth Bienvenu, PhD and Gay Hanna, PhD, MFA Arts participation can counterbalance the social stigma of Alzheimer’s disease by fostering the autonomy and creativity of those with the diagnosis. AMA J Ethics. 2017;19(7):704-712. doi: 10.1001/journalofethics.2017.19.7.msoc2-1707. Medicine and Society Oct 2019 Which Ethical Considerations Should Inform Hospice Decisions About Caring for Patients With Obesity? Chithra R. Perumalswami, MD, MSc, Brycin D. Hanslits, and Susan D. Goold, MD, MA, MHSA Current evidence suggests how hospice and palliative care clinicians can help advocate for high-quality, end-of-life care for patients with obesity. AMA J Ethics. 2019;21(10):E873-878. doi: 10.1001/amajethics.2019.873.
Medicine and Society Jul 2019 Who Are “Unrepresented” Patients and What Count as “Important” Medical Decisions for Them? David Ozar, PhD A look at current literature and work by a statewide initiative can motivate development of policies that help respond to unrepresented patients’ needs. AMA J Ethics. 2019;21(7):E611-616. doi: 10.1001/amajethics.2019.611.
Medicine and Society Feb 2021 Should Clinical Guidelines Incorporate Cost Pathways for Persons With Financial Hardship? David Goldberg, MD Standard treatment of hyperglycemia in type 2 diabetes includes a pathway when “cost is a major issue.” Whether it’s just to do so remains unclear. AMA J Ethics. 2021;23(2):E175-182. doi: 10.1001/amajethics.2021.175.
Medicine and Society Jul 2017 Transcending the Tragedy Discourse of Dementia: An Ethical Imperative for Promoting Selfhood, Meaningful Relationships, and Well-Being Peter Reed, PhD, MPH, Jennifer Carson, PhD, and Zebbedia Gibb, PhD Authentic partnerships with people with dementia motivate full social participation and resist fatalism around experiences of illness. AMA J Ethics. 2017;19(7):693-703. doi: 10.1001/journalofethics.2017.19.7.msoc1-1707.
Medicine and Society Jul 2017 Arts Participation: Counterbalancing Forces to the Social Stigma of a Dementia Diagnosis Beth Bienvenu, PhD and Gay Hanna, PhD, MFA Arts participation can counterbalance the social stigma of Alzheimer’s disease by fostering the autonomy and creativity of those with the diagnosis. AMA J Ethics. 2017;19(7):704-712. doi: 10.1001/journalofethics.2017.19.7.msoc2-1707.
Medicine and Society Oct 2019 Which Ethical Considerations Should Inform Hospice Decisions About Caring for Patients With Obesity? Chithra R. Perumalswami, MD, MSc, Brycin D. Hanslits, and Susan D. Goold, MD, MA, MHSA Current evidence suggests how hospice and palliative care clinicians can help advocate for high-quality, end-of-life care for patients with obesity. AMA J Ethics. 2019;21(10):E873-878. doi: 10.1001/amajethics.2019.873.